arrow
J

Julius Popp

Lausanne University Hospital
H指数:57
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

APOE-stratified genome-wide association analyses provide insights into the genetic etiology of Alzheimers’s disease

APOE分层的全基因组关联分析为阿尔茨海默病的遗传病因提供了见解

2026-09-140
OAAI
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease

Rabl, M.; Hartog, W.L.; van der Flier, W.M.; Pijnenburg, Y.A.L.; Teunissen, C.E.; Tsolaki, M.; Freund-Levi, Y.; Vandenberghe, R.; Froelich, L.; Streffer, J.; et al. 与认知衰退和阿尔茨海默病中抑郁症状相关的脑脊液蛋白质组改变。Alzheimers Dement. 2025, 21, e71054. [Google Scholar] [CrossRef]

2025-12-261
OAAI
The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts

糖尿病与阿尔茨海默病生物标志物及血管负担在欧洲老龄化与记忆诊所队列中的关联

2025-10-300
OAAI
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease

APOE基因型与脑脊液蛋白质组的关联揭示了阿尔茨海默病中不同的保护机制和风险机制

2025-10-140
OAAI
Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer Disease: Intersocietal Recommendations for Their Appropriate Use in Switzerland

Felbecker A, Rouaud O, Lathuilliere A. 等. 抗淀粉样蛋白单克隆抗体用于阿尔茨海默病治疗:瑞士跨学会关于其合理使用的建议. 神经退行性疾病, 2025; 14: 1–12.

2025-10-012
OAAI
Machine learning in Alzheimer’s disease genetics

阿尔茨海默病遗传学中的机器学习

2025-07-220
OAAI
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology

认知功能正常个体中疑似非阿尔茨海默病病理生理机制的脑脊液蛋白质组学分析

2025-06-200
OAAI
Transferability of European-derived Alzheimer’s disease polygenic risk scores across multiancestry populations

欧洲来源的阿尔茨海默病多基因风险评分在多祖先人群中的可转移性

2025-06-180
OA
Synaptic protein CSF levels relate to memory scores in individuals without dementia

突触蛋白CSF水平与无痴呆个体的记忆评分相关

2025-03-030
OA
Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer's disease in the EMIF-AD study

Emif-ad研究中与阿尔茨海默病CSF生物标志物相关的血液DNA甲基组学特征

2024-08-280
OAAI
Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression

血浆神经丝光、胶质纤维酸性蛋白和磷酸化tau 181作为神经精神症状和相关临床疾病进展的生物标志物

2024-07-251
OAAI
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies
2024-07-183
OAAI
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
2024-07-061
OA
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning

阿尔茨海默病CSF生物标志物谱的多变量gis暗示突触功能中的GRIN2D

2023-10-045
OAAI
Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

阿尔茨海默氏症和帕金森氏病中HLA基因座的多血统分析揭示了由HLA-DRB1 * 04亚型介导的共享适应性免疫反应

2023-08-299
OAAI
Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

可改变的危险因素与阿尔茨海默病之间的遗传关联

2023-05-1737
OAAI